Offer - Urjas Oil for just ₹ 1
Keziderm is an allopathic medicine The correct dosage of Keziderm depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Keziderm is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Keziderm is used -
Severe
Moderate
Mild
Common
Is the use of Keziderm safe for pregnant women?
Keziderm should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Keziderm safe during breastfeeding?
Breastfeeding women can safely use Keziderm.
What is the effect of Keziderm on the Kidneys?
Keziderm rarely affects the kidneys.
What is the effect of Keziderm on the Liver?
Keziderm is completely safe for the liver.
What is the effect of Keziderm on the Heart?
Using Keziderm does not have any harmful effects on the heart.
Keziderm should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Keziderm unless your doctor advises you to do so -
Is this Keziderm habit forming or addictive?
No, there is no any evidence that Keziderm is addictive.
Interaction between Food and Keziderm
Taking Keziderm with food is safe.
Interaction between Alcohol and Keziderm
Due to lack of research, there is no information about the side effects of taking Keziderm with alcohol.
No, Keziderm Should not be stopped or discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine. Suddenly stopping Keziderm can cause withdrawal symptoms such as fever, joint pain, and feeling of discomfort. To avoid the withdrawal symptoms, the dosage of this drug should be reduced gradually. Please consult your doctor if you are experiencing any withdrawal symptoms after stopping/discounting it on your own.
Yes, Keziderm can be taken with paracetamol. No harmful drug interaction has been reported between them. However, if you feel any unpleasant effects then consult your doctor.
Yes, Keziderm can be taken with phenylephrine. No harmful drug interactions have been reported between them. However, if you feel any discomfort or unpleasant effects after taking this drug to inform your doctor immediately.
Yes, Keziderm is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at therapeutic doses such as fluid retention (swelling in your hands or ankles), increased appetite, increased sweating, and stomach upset. Do not hesitate to inform your doctor if you are facing any of the above.
Take Keziderm as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gentamicin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 747-748
